Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like Asra Minerals August 16, 2025 Coelacanth Energy Inc. Announces Grant of Stock Options... January 27, 2026 Lithium Universe LtdAcquisition of Solar Panel Recycling Technology June 18, 2025 Silver Crown Royalties Announces Closing of Final Tranche... April 28, 2025 Navigating Uncertainty: How to Manage Jurisdictional Risk for... September 10, 2025 Lo Herma Hydrogeology Testing & Resource Expansion Drilling September 18, 2025 Commencement of Henbury Field Program September 1, 2025 Tech 5: Softbank to Invest US$2 Billion in... August 24, 2025 Armory Mining Provides Corporate Update January 19, 2026 Editor’s Picks: Gold and Silver Prices Hit New... January 31, 2026
